 |
|
|
| |
High Rapid Virologic Response (RVR) with PSI-7977 Daily Dosing plus PEG-IFN/RBV
in a 28-day Phase 2a Trial
|
| |
| |
Reported by Jules Levin
AASLD Nov 1 2010 Boston
Lawitz E1, Lalezari J2, Rodriguez-Torres M3, Kowdley KV4, Nelson DR5, DeJesus E6, McHutchison JG7, Cornpropst MT8, Mader M8, Albanis E8, Symonds WT8, Berrey MM8
1Alamo Medical Research, San Antonio, TX, 2Quest Clinical Research, San Francisco, CA, 3Fundacion de Investigacion de Diego, Santurce, PR, 4 Virginia Mason Medical Center, Seattle, WA, 5 University of Florida, Gainesville, FL, 6Orlando Immunology Center, Orlando, FL, 7 Duke Clinical Research Institute, Durham, NC, 8Pharmasset, Inc., Princeton, NJ
|
| |
|
|
|
|
|
